RETRACTED ARTICLE:Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11005-11011

  Wang, Jiajun ^a   Su, Hongying ^a   Han, Xiangjun ^a   Xu, Ke ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

ERK MAPK; Fibroblast growth factor receptor 2; Hepatocellular carcinoma; HepG2; HuH 7; JNK; MMP26; MMP7; PI3K

Indexed keywords

ENZYME INHIBITOR; FGFR2 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; MMP27 PROTEIN, HUMAN; MMP7 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASES, SECRETED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84928584910     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2384-0     Document Type: TB

References (27)

1. Wang L, Yao M, Dong Z, Zhang Y, Yao D. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour Biol. 2014;35:9–20.
2. Wang H, Chen L. Tumor microenviroment and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol. 2013;28 Suppl 1:43–8.
3. Han MS, Moon KS, Lee KH, Cho SB, Lim SH, Jang WY, et al. Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor. BMC Cancer. 2013;13:567.
4. Takaishi H, Kimura T, Dalal S, Okada Y, D’Armiento J. Joint diseases and matrix metalloproteinases: a role for mmp-13. Curr Pharm Biotechnol. 2008;9:47–54.
5. Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (mmp-1, mmp-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4:157–64.
6. Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP, Lopez-Otin C. Expression and regulation of collagenase-3 (mmp-13) in human malignant tumors. APMIS. 1999;107:45–53.
7. Tanimoto H, Underwood LJ, Shigemasa K, Parmley TH, Wang Y, Yan Y, et al. The matrix metalloprotease pump-1 (mmp-7, matrilysin): a candidate marker/target for ovarian cancer detection and treatment. Tumour Biol. 1999;20:88–98.
8. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstrom J, et al. Mmp-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol. 2010;31:149–55.
9. Koskensalo S, Louhimo J, Nordling S, Hagstrom J, Haglund C. Mmp-7 as a prognostic marker in colorectal cancer. Tumour Biol. 2011;32:259–64.
10. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2006;231:20–7.
11. Liu G, Jiang C, Li D, Wang R, Wang W. Mirna-34a inhibits egfr-signaling-dependent mmp7 activation in gastric cancer. Tumour Biol. 2014.
12. Zhang Y, Zhao H, Wang Y, Lin Y, Tan Y, Fang X, et al. Non-small cell lung cancer invasion and metastasis promoted by mmp-26. Mol Med Rep. 2011;4:1201–9.
13. Li D. Peaking of mmp-26 and timp-4 marks invasive transition in prostate cancer. Cell Res. 2006;16:741.
14. Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, et al. Association of matrilysin-2 (mmp-26) expression with tumor progression and activation of mmp-9 in esophageal squamous cell carcinoma. Carcinogenesis. 2004;25:2353–60.
15. Friesel R, Maciag T. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb Haemost. 1999;82:748–54.
16. Jaye M, Schlessinger J, Dionne CA. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta. 1992;1135:185–99.
17. Wang X, Cao X. Regulation of metastasis of pediatric multiple myeloma by mmp13. Tumour Biol. 2014.
18. Fujimoto J, Hori M, Ichigo S, Tamaya T. Expressions of the fibroblast growth factor family (fgf-1, −2 and −4) mrna in endometrial cancers. Tumour Biol. 1996;17:226–33.
19. Soundararajan P, Fawcett JP, Rafuse VF. Guidance of postural motoneurons requires mapk/erk signaling downstream of fibroblast growth factor receptor 1. J Neurosci. 2010;30:6595–606.
20. Kuslak SL, Marker PC. Fibroblast growth factor receptor signaling through mek-erk is required for prostate bud induction. Differentiation. 2007;75:638–51.
21. Williamson AJ, Dibling BC, Boyne JR, Selby P, Burchill SA. Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38mapk and up-regulation of the death receptor p75ntr. J Biol Chem. 2004;279:47912–28.
22. Kan M, Wu X, Wang F, McKeehan WL. Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J Biol Chem. 1999;274:15947–52.
23. Fletcher MN, Castro MA, Wang X, de Santiago I, O’Reilly M, Chin SF, et al. Master regulators of fgfr2 signalling and breast cancer risk. Nat Commun. 2013;4:2464.
24. Liao RG, Jung J, Tchaicha J, Wilkerson MD, Sivachenko A, Beauchamp EM, et al. Inhibitor-sensitive fgfr2 and fgfr3 mutations in lung squamous cell carcinoma. Cancer Res. 2013;73:5195–205.
25. Kang M, Choi S, Jeong SJ, Lee SA, Kwak TK, Kim H, et al. Cross-talk between tgfbeta1 and egfr signalling pathways induces tm4sf5 expression and epithelial-mesenchymal transition. Biochem J. 2012;443:691–700.
26. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, et al. M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A. 2014;111:E1211–20.
27. Xu Y, Xia W, Baker D, Zhou J, Cha HC, Voorhees JJ, et al. Receptor-type protein tyrosine phosphatase beta (rptp-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (hgfr/met) function. J Biol Chem. 2011;286:15980–8.